Crisis at Organon: Leadership Ousted Amid Sales Scandal

Market Reaction and Analyst Downgrades

The pharmaceutical firm Organon & Co. is confronting its most severe corporate challenge to date following the discovery of manipulated sales figures. This controversy has not only resulted in the departure of its chief executive but has also inflicted significant damage on investor confidence. The company now faces critical questions about its future viability and the possibility of a strategic recovery.